Project Grant H8G48513

This $344,222.00 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) will support the Virginia Department of Health (VDH) in enhancing vaccine-preventable disease prevention and response efforts across the state. The project period runs from July 1, 2025 to June 30, 2030. Key objectives include bolstering immunization infrastructure, improving disease surveillance, and expanding community...

This $568,050 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) supports the U.S. Virgin Islands Department of Health in strengthening its Vaccines for Children program and related immunization initiatives. Key objectives include enhancing vaccination coverage, identifying underserved and vaccine-hesitant populations, and improving data quality and interoperability of the territory's...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Investigations and Technical Assistance program (CFDA 93.283), provides $226,948 to the Health Services Kentucky Cabinet For to strengthen vaccine-preventable disease prevention and response in the Commonwealth of Kentucky. The funding will be used to: 1) Improve immunization outreach and services across the state, 2) Meet CDC vaccination requirements, and 3) Respond to emergencies and public...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the CDC Investigations and Technical Assistance program (CFDA 93.283), aims to enhance vaccine coverage and prevent outbreaks of vaccine-preventable diseases (VPDs) in Puerto Rico. With a total funding amount of $1,400,897.00 and a period of performance from July 1, 2025 to June 30, 2030, the project will focus on three key strategies: Providing training and technical assistance to vaccine providers...

This is a Cooperative Agreement awarded by the U.S. Centers for Disease Control and Prevention (CDC), under the Immunization Cooperative Agreements program (CFDA 93.268), to the FSM Department of Health and Social Affairs. The $1,186,841 award, effective July 1, 2025 through June 30, 2030, will support strengthening vaccine-preventable disease prevention and response efforts in the Federated States of Micronesia. The key objectives are to improve vaccination coverage rates, enhance...

This $1,307,989 Cooperative Agreement awarded by the National Center for Immunization and Respiratory Diseases (a civilian agency) under the Grants to States for Medicaid (CFDA 93.778) program supports the Hawaii Department of Health's efforts to strengthen vaccine-preventable disease prevention and response in Hawaii. The key products and services to be delivered include: Educating healthcare providers and the general public about immunizations, especially given Hawaii's diverse population...

This Cooperative Agreement award of $3,996,516.00, funded by the Centers for Disease Control and Prevention (CDC) Immunization Cooperative Agreements (CFDA 93.268) program, supports the Arizona Department of Health Services (ADHS) in strengthening vaccine-preventable disease prevention and response efforts. The key products and services to be delivered under this 5-year project (July 1, 2025 to June 30, 2030) include: Improving vaccine management and provider support to ensure efficient...

The Indiana Department of Health (IDOH) was awarded a $285,280 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) with a project period from July 1, 2025 to June 30, 2030. This award aims to increase immunization rates, improve vaccine accessibility, and reduce disparities in Indiana through data-driven strategies and targeted outreach. Key initiatives include expanding the vaccine replacement model for...

This Cooperative Agreement award from the Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases (CFDA 93.778 - Grants to States for Medicaid) provides $1,991,334 to the State of Alaska Department of Health from July 1, 2025 to June 30, 2030. The funding will support the State of Alaska's Immunization Program in improving vaccination access and coverage, reducing disparities, enhancing disease surveillance and outbreak response readiness, and...

The Palau Ministry of Health was awarded a $100,000 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) to support the Palau Strengthening Vaccine-Preventable Disease Prevention and Response initiative. The award, effective July 1, 2025 through June 30, 2030, will sustain the public health infrastructure for vaccine delivery, maintain adequate vaccine supply, and enhance vaccination response and readiness...